C.-Z. Wang, Z.-J. Pang, Z.-D. Yu et al.
Tetrahedron 78 (2021) 131828
for 24 h. The mixture was cooled to room temperature, and the
mixture was quenched with water, extracted with CH2Cl2
(2 ꢂ 100 mL), and washed with water and brine. The organic ex-
tracts were dried with MgSO4 powder and the solvent was
evaporated.
(100 MHz, CDCl3)
d
(ppm) ¼ 192.13, 150.26, 146.45, 136.65, 135.57,
131.36, 131.25, 130.98, 130.82, 130.03, 129.82, 129.55, 128.65, 127.84,
126.25, 125.89, 124.42, 123.54, 123.40, 122.56, 119.62, 35.43, 32.00.
FAB-MS: m/z calcd for C27H21BrO 440.0776 [Mþ]; found 440.0775
[Mþ].
4.3. Synthesis of 7-tert-butyl-1-phenylpyrene (4a)
4.7. Synthesis of 7-tert-butyl-1-phenyl-3-(4-N,N-
dimethylaminophenylethynyl)pyrene (6a)
A
similar procedure with phenylboronic acid (488 mg,
4.0 mmol), was followed for the synthesis of 4a [36]. 4a was ob-
tained as white solid (recrystallized from hexaneeCHCl3 (9:1);
A mixture of 7-tert-butyl-1-phenyl-3-bromopyrene 5a (150 mg,
0.36 mmol), N,N-dimetylaminophenyl acetylene (105 mg,
0.73 mmol), PPh3 (9 mg, 0.036 mmol), CuI (7 mg, 0.36 mmol),
PdCl2(PPh3)3 (13 mg, 0.036 mmol) were added to a degassed so-
lution of DMF (8 mL) and Et3N (8 mL). The resulting mixture was
stirred at 100 ꢁC for 24 h. After it was cooled to room temperature,
the reaction was quenched with water. The mixture was extracted
with CH2Cl2 (2 ꢂ 50 mL), the organic layer was washed with water
(2 ꢂ 30 mL) and brine (30 mL), and then the solution was dried
(MgSO4), and evaporated. The residue was purified by column
chromatography eluting with a hexaneeCHCl3 (3:2) mixture to give
6a as a yellow crystalline powder (86.1 mg, 50%). M.p. 206e208 ꢁC;
510 mg, 76%). 1H NMR (400 MHz, CDCl3)
d
(ppm) ¼ 1.58 (s, 9H, tBu),
7.48 (m, 1H, Ar-H), 7.56 (t, J ¼ 7.4, 2H, Ar-H), 7.64 (d, J ¼ 7.7 Hz, 2H,
Ar-H), 7.94 (d, J ¼ 7.8 Hz, 1H, pyrene-H), 8.00 (d, J ¼ 9.3 Hz, 1H,
pyrene-H), 8.07 (d, J ¼ 1.5 Hz, 2H, pyrene-H), 8.14 (d, J ¼ 9.3 Hz, 1H,
pyrene-H), 8.18 (d, J ¼ 8.0 Hz, 1H, pyrene-H), 8.21 (d, J ¼ 9.3 Hz, 1H,
pyrene-H), 8.22 (d, J ¼ 9.3 Hz, 1H, pyrene-H).
4.4. Synthesis of 7-tert-butyl-1-(4-formylphenyl)pyrene (4b)
A similar procedure with 4-formylphenylboronic acid (600 mg,
4.0 mmol), was followed for the synthesis of 4b. 4b was obtained as
yellow solid (recrystallized from hexaneeCHCl3 (6:1); 379 mg,
1H NMR (400 MHz, CDCl3)
d
(ppm) ¼ 1.59 (s, 9H, tBu), 3.03 (s, 6H,
NMe2), 6.74 (d, J ¼ 7.2 Hz, 2H, Ar-H), 7.49 (d, J ¼ 7.0 Hz, 1H, Ar-H),
7.54e7.62 (m, 4H, Ar-H), 7.65 (d, J ¼ 7.1 Hz, 2H, Ar-H), 7.99 (d,
J ¼ 9.0 Hz, 1H, pyrene-H), 8.10 (d, J ¼ 8.8 Hz, 1H, pyrene-H), 8.17 (m,
3H, pyrene-H), 8.25 (s, 1H, pyrene-H), 8.68 (d, J ¼ 8.9 Hz, 1H, pyr-
53%). M.p.134e136 ꢁC; 1H NMR (400 MHz, CDCl3)
d
(ppm) ¼ 1.59 (s,
9H, tBu), 7.83 (d, J ¼ 8.0 Hz, 2H, Ar-H), 7.94 (d, J ¼ 7.8 Hz, 2H, Ar-H),
8.04 (d, J ¼ 9.3 Hz, 1H, Ar-H), 8.06e8.12 (m, 5H, pyrene-H),
8.19e8.25 (m, 2H, pyrene-H), 10.16 (s, 1H, CHO), FAB-MS: m/z calcd
for C27H22O 362.1671 [Mþ]; found 362.1670 [Mþ].
ene-H). 13C NMR (100 MHz, CDCl3)
d
(ppm) ¼ 149.50,140.86, 137.33,
133.00, 131.50, 131.15, 130.81, 130.67, 128.49, 128.27, 128.06, 127.45,
125.83, 125.22, 122.91, 122.59, 118.49, 112.05, 96.57, 87.72, 40.44,
35.36, 32.04. FAB-MS: m/z calcd for C36H31N 477.2457 [Mþ]; found
477.2454 [Mþ].
4.5. Synthesis of 7-tert-butyl-1-phenyl-3-bromopyrene (5a)
Compound 7-tert-butyl-1-phenylpyrene 4a (334 mg, 1.0 mmol)
was added to CH2Cl2 (9 mL) and MeOH (25 mL), and the mixture
was stirred under argon atmosphere at 0 ꢁC. After 30 min, BTMABr3
(585 mg, 1.5 mmol) was added. The resulting mixture was stirred
for 6 h at room temperature under argon. The mixture was
extracted with CH2Cl2 (2 ꢂ 50 mL), and the combined extracts were
washed with water and brine, dried with MgSO4 powder and
concentrated. The residue was chromatographed over silica gel
(Wako C-300, 200 g) with hexaneeCHCl3 (9:1) as eluent to give a
white solid (366 mg, 88%). M.p. 110e112 ꢁC; 1H NMR (400 MHz,
4.8. Synthesis of 7-tert-butyl-1-(4-formylphenyl)-3-(4-N,N-
dimethylaminophenylethynyl)pyrene (6b)
A mixture of 7-tert-butyl-1-(4-formylphenyl)-3-bromopyrene
5b (120 mg, 0.27 mmol), N,N-dimetylaminophenyl acetylene
(78 mg, 0.54 mmol), PPh3 (6.7 mg, 0.027 mmol), CuI (5 mg,
0.27 mmol), PdCl2(PPh3)3 (10 mg, 0.027 mmol) were added to a
degassed solution of DMF (6 mL) and Et3N (6 mL). The resulting
mixture was stirred at 100 ꢁC for 24 h. After it was cooled to room
temperature, the reaction was quenched with water. The mixture
was extracted with CH2Cl2 (2 ꢂ 40 mL), the organic layer was
washed with water (2 ꢂ 30 mL) and brine (30 mL), and then the
solution was dried (MgSO4), and evaporated. The residue was pu-
rified by column chromatography eluting with a hexaneeCHCl3
(1:1) mixture to give 6b as an orange crystalline powder (53.5 mg,
CDCl3)
d
(ppm) ¼ 1.59 (s, 9H, tBu), 7.47e7.62 (m, 5H, Ar-H), 7.94 (d,
J ¼ 8.0 Hz, 1H, pyrene-H), 8.01 (d, J ¼ 9.2 Hz, 1H, pyrene-H), 8.08 (d,
J ¼ 9.3 Hz, 1H, pyrene-H), 8.17 (d, J ¼ 9.2 Hz, 1H, pyrene-H),
8.20e8.24 (m, 2H, pyrene-H), 8.27 (s, 1H, pyrene-H), 8.43 (d, J ¼ 9.2,
1H, pyrene-H). FAB-MS: m/z calcd for C26H21Br 412.0827 [Mþ];
found 412.0827 [Mþ].
39%). M.p. 255e257 ꢁC; 1H NMR (400 MHz, CDCl3)
d
(ppm) ¼ 1.60
4.6. Synthesis of 7-tert-butyl-1-(4-formylphenyl)-3-bromopyrene
(5b)
(s, 9H, tBu), 3.04 (s, 6H, NMe2), 6.74 (d, J ¼ 7.5 Hz, 2H, Ar-H), 7.60 (d,
J ¼ 8.9 Hz, 2H, Ar-H), 7.83 (d, J ¼ 7.8 Hz, 2H, Ar-H), 8.03 (s, 2H,
pyrene-H), 8.07 (d, J ¼ 7.8 Hz, 2H, Ar-H), 8.09 (s, 1H, pyrene-H), 8.18
(d, J ¼ 10.2 Hz, 1H, pyrene-H), 8.22 (s, 1H, pyrene-H), 8.29 (s, 1H,
Compound 7-tert-butyl-1-(4-formylphenyl)pyrene 4b (200 mg,
0.56 mmol) was added to CH2Cl2 (5 mL), MeOH (15 mL), and the
mixture was stirred under argon atmosphere at 0 ꢁC. After 30 min,
BTMABr3 (328 mg, 0.84 mmol) was added. The resulting mixture
was stirred for 6 h at room temperature under argon. The mixture
was extracted with CH2Cl2 (2 ꢂ 30 mL), and the combined extracts
were washed with water and brine, dried with MgSO4 powder and
concentrated. The residue was chromatographed over silica gel
(Wako C-300, 150 g) with hexaneeCHCl3 (7:1) as eluent to give a
pale-yellow solid (240 mg, 98%). M.p. 122e124 ꢁC; 1H NMR
pyrene-H), 8.69 (d, J ¼ 10.0 Hz, 1H, pyrene-H), 10.16 (s, 1H, CHO). 13
C
NMR (100 MHz, CDCl3)
d
(ppm) ¼ 192.23, 150.41, 149.78, 147.40,
135.65, 135.39, 133.03, 131.48, 131.39, 131.34, 130.90, 131.07, 130.28,
129.95,128.77, 128.62, 127.84,125.79,125.07, 124.52, 123.32, 122.99,
122.92, 118.75, 112.04, 110.14, 97.06, 86.58, 40.38, 35.40, 32.02. FAB-
MS: m/z calcd for C37H31NO 505.2406 [Mþ]; found 505.2357 [Mþ].
Declaration of competing interest
(400 MHz, CDCl3)
d
(ppm) ¼ 1.52 (s, 9H, tBu), 7.73 (d, J ¼ 7.7 Hz, 2H,
Ar-H), 7.97 (d, J ¼ 7.7 Hz, 2H, Ar-H), 8.02 (d, J ¼ 7.9 Hz, 2H, pyrene-
H), 8.15 (d, J ¼ 7.9 Hz, 2H, pyrene-H), 8.19 (s, 1H, pyrene-H), 8.24 (s,
1H), 8.38 (d, J ¼ 9.3 Hz, 1H, pyrene-H), 10.10 (s, 1H, CHO). 13C NMR
The authors declare that they have no known competing
financial interests or personal relationships that could have
appeared to influence the work reported in this paper.
5